Insights

Immunoperoxidase staining detected Hepatitis B surface antigen (HBsAg) in 19.15% of liver cirrhosis biopsies. This sensitive method aids diagnosis, particularly in postnecrotic cases from endemic areas.

Area of Science:

  • Hepatology
  • Immunohistochemistry
  • Virology

Background:

  • Cirrhosis is a late stage of liver scarring.
  • Hepatitis B virus (HBV) is a major cause of liver disease.
  • Immunoperoxidase (IP) staining is a valuable diagnostic tool.

Purpose of the Study:

  • To determine the prevalence of Hepatitis B surface antigen (HBsAg) in liver cirrhosis biopsies using immunoperoxidase (IP) staining.
  • To evaluate the utility of IP staining in diagnosing cirrhosis, especially in endemic regions.

Main Methods:

  • 47 liver biopsies with a diagnosis of cirrhosis were analyzed.
  • Immunoperoxidase (IP) staining was employed to detect HBsAg.
  • Biopsies were categorized into postnecrotic (PN) and non-postnecrotic (NP) cirrhosis.

Main Results:

  • HBsAg was detected in 9 out of 47 biopsies (19.15%).
  • All positive cases (9) were associated with postnecrotic (PN) hepatic cirrhosis.
  • The IP method demonstrated high sensitivity and specificity.

Conclusions:

  • Immunoperoxidase staining is a sensitive and specific method for detecting HBsAg in liver cirrhosis.
  • This technique is particularly useful as an auxiliary diagnostic tool in endemic zones and for challenging cases.
  • The findings highlight the association of HBsAg with postnecrotic cirrhosis.